Registry of Lobbyists
Total Number of Communication Reports: 1
Monthly communication reports in the last 6 months: 0
Version 4 of 10 (2007-03-13 to 2007-12-12) was submitted prior to the Lobbying Act coming into force on July 2, 2008. Due to different information requirements at that time, the registration is presented in the following format.
| Corporation: |
Solvay Pharma Inc.
102 - 60 Columbia Way Markham, ON L3R 0C9 Canada |
| Telephone number: | 905-944-2480 Ext.: 203 |
| Fax number: | 905-944-2481 |
| Responsible officer name and position during the period of this registration: | Graham Jobson, President & CEO |
| Description of activities: | Solvay Pharma Inc. is a reasearch-based pharmaceutical company. It's head office is in Markham, Ontario and it has a manufacturing facility in Victoriaville, Quebec. |
| The client is a subsidiary of the following parent companies: |
Solvay S.A.
rue du Prince Albert 33 B-1050 Brussels Belgium |
| Coalition | The corporation is not a member of a coalition. |
| Subsidiary: | The corporation does not have any subsidiaries that could be affected by the outcome of the undertaking. |
| Other direct interests | The corporation's activities are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking. |
| Was the corporation funded in whole or in part by any domestic or foreign government institution in the last completed financial year? | No |
| Name: | Sean Webster |
| Position title: | Vice President, Corporate Affairs |
| Public offices held: | Yes |
| Federal departments or organizations which have been or will be communicated with during the course of the undertaking: | Health Canada (HC), Industry Canada, Members of the House of Commons, Public Works and Government Services Canada | ||||
|
Communication techniques that have been used or are expected to be used in the course of the undertaking:
|
Informal communications, Meetings, Presentations, Telephone calls, Written communications, whether in hard copy or electronic format | ||||
| Subject Matter: Areas of Concern: | Government Procurement, Health, Industry, Intellectual Property, Science and Technology | ||||
| Subject Matter: Retrospective: | Meetings with federal officials on pharmaceutical and health policy matters | ||||
| Subject Matter: Prospective: | Meetings with federal officials on pharmaceutical and health policy matters | ||||
Details Regarding the Identified Subject Matter
|
|||||